-
Featured
Treatments for Benign Prostatic Hyperplasia
Current treatments generally focus on oral medications or invasive surgery, which can have side effects. The prostatic urethral lift and water steam therapy are effective, non-invasive treatments for BPH.
-
Featured
Multiparametric MRI/Ultrasound Fusion Biopsy Improves Prostate Cancer Detection
Active surveillance (AS) has become an accepted way to manage prostate cancer in men at lower risk. Multiparametric MRI can be used in conjunction with the standard transrectal ultrasound (TRUS)-guided biopsy to improve detection of clinically significant cancers.
-
Featured
BPH Supplements Have Little Support for Efficacy and Safety
To better advise patients about herbal remedies for prostate enlargement or benign prostatic hyperplasia (BPH), researchers scoured the scientific literature for evidence on every individual ingredient of every available supplement.
-
New Target Discovered for Prostate Cancer Immunotherapy
Genitourinary pathologists at Massachusetts General Hospital are the first to demonstrate that PD-L1 expression is highly prevalent in prostate tumor-associated nerves. Such nerves may represent an important target for immunotherapy regimens.
-
Crucial miRNA–mRNA Regulatory Network Involved in Prostate Carcinogenesis Identified
Massachusetts General Hospital investigators identified miRNAs-mRNA pairs involved in prostate cancer and constructed a prostate cancer gene network based on these pairs and their connected biological pathways.
-
Molecular Testing Shows Promise for Predicting Outcomes of Patients with RCC
By combining clinicopathologic variables and a cell cycle gene assay, researchers have created a new way to predict survival of patients with localized renal cell carcinoma (RCC) who have undergone nephrectomy.
Prostate contributors
-
Adam Scott Feldman, MD, MPH
Director, Combined Harvard Urologic Oncology Fellowship
Recent Article
Molecular Testing Shows Promise for Predicting Outcomes of Patients with RCC
-
Douglas Middleton Dahl, MD
Chief, Division of Urologic Oncology, Director of Robotic Surgery, Associate Professor, Harvard Medical School
Recent Article
Noninvasive Assay Predicts Drug Response, Early Dissemination in Prostate Cancer
-
Francis James McGovern, MD
Urologist
Recent Article
Due to Current Opioid Crisis, Urologists Must Combat Opioid Overprescription
-
Jason A. Efstathiou, MD, Dphil
Director, Genitourinary Service, Department of Radiation Oncology, Clinical Co-Director, The Claire and John Bertucci Center for Genitourinary Cancers Multidisciplinary Clinic
Recent Article
Review: Molecular Biomarkers May Lead to Personalized Treatment of Muscle-invasive Bladder Cancer -
Matthew F. Wszolek, MD
Assistant in Urology, Massachusetts General Hospital, Instructor in Surgery, Harvard Medical School
Recent Article
New Clues Emerge on Management of Recurrent Nonmuscle Invasive Bladder Cancer After Trimodality Therapy
-
Mukesh G. Harisinghani, MD
Director, Abdominal MRI
Recent Article
Improving the Safety of Vena Caval Thrombectomy in Kidney Cancer with Tumor Thrombus Team Approach -
Shahin Tabatabaei, MD
Director, Prostate Health Program
Recent Article
BPH Supplements Have Little Support for Efficacy and Safety
Urology Care at Mass General
The Department of Urology at Massachusetts General Hospital offers sophisticated, compassionate care and the most innovative treatments for patients with any type of urological condition.Resource Links
